Figure 2.

Percent inhibition of plasma DPP activity in human, rhesus monkey and cynomolgus monkey plasma by saxagliptin using ala-pro-AFC as substrate.

Wang et al. BMC Pharmacology 2012 12:2   doi:10.1186/1471-2210-12-2
Download authors' original image